van Roy F - Search Results

1

Mutations of the human E-cadherin (CDH1) gene.

Berx G, Becker KF, Höfler H, van Roy F. Berx G, et al. Among authors: van roy f. Hum Mutat. 1998;12(4):226-37. doi: 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 1998. PMID: 9744472 Review.

2

Involvement of members of the cadherin superfamily in cancer.

Berx G, van Roy F. Berx G, et al. Among authors: van roy f. Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a003129. doi: 10.1101/cshperspect.a003129. Epub 2009 Sep 23. Cold Spring Harb Perspect Biol. 2009. PMID: 20457567 Free PMC article. Review.

3

Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1).

Berx G, Staes K, van Hengel J, Molemans F, Bussemakers MJ, van Bokhoven A, van Roy F. Berx G, et al. Among authors: van hengel j, van roy f, van bokhoven a. Genomics. 1995 Mar 20;26(2):281-9. doi: 10.1016/0888-7543(95)80212-5. Genomics. 1995. PMID: 7601454

4

E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.

Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. Berx G, et al. Among authors: van roy f, van de vijver m. EMBO J. 1995 Dec 15;14(24):6107-15. doi: 10.1002/j.1460-2075.1995.tb00301.x. EMBO J. 1995. PMID: 8557030 Free PMC article.

5

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C. Berx G, et al. Among authors: van roy f. Oncogene. 1996 Nov 7;13(9):1919-25. Oncogene. 1996. PMID: 8934538

6

An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene.

Berx G, Nollet F, Strumane K, van Roy F. Berx G, et al. Among authors: van roy f. Hum Mutat. 1997;9(6):567-74. doi: 10.1002/(SICI)1098-1004(1997)9:6<567::AID-HUMU11>3.0.CO;2-0. Hum Mutat. 1997. PMID: 9195232

7

Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas.

Berx G, Nollet F, van Roy F. Berx G, et al. Among authors: van roy f. Cell Adhes Commun. 1998;6(2-3):171-84. doi: 10.3109/15419069809004474. Cell Adhes Commun. 1998. PMID: 9823469 Review.

8

Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online.

Becker KF, Reich U, Schott C, Becker I, Berx G, van Roy F, Höfler H. Becker KF, et al. Among authors: van roy f. Hum Mutat. 1999;13(2):171. doi: 10.1002/(SICI)1098-1004(1999)13:2<171::AID-HUMU14>3.0.CO;2-Z. Hum Mutat. 1999. PMID: 10094558

9

The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer.

Nollet F, Berx G, van Roy F. Nollet F, et al. Among authors: van roy f. Mol Cell Biol Res Commun. 1999 Aug;2(2):77-85. doi: 10.1006/mcbr.1999.0155. Mol Cell Biol Res Commun. 1999. PMID: 10542129 Review.

10

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.

Berx G, Van Roy F. Berx G, et al. Among authors: van roy f. Breast Cancer Res. 2001;3(5):289-93. doi: 10.1186/bcr309. Epub 2001 Jun 28. Breast Cancer Res. 2001. PMID: 11597316 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters